Therapeutic Use of Psychedelics for Mental Disorders: A Systematized Review
N. Alyahya, Eithar A. Al Saleem
Journal of Nature and Science of Medicine December 17, 2024 DOI: 10.4103/jnsm.jnsm_76_24 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Systematic review Peer reviewed |
|---|---|
| Citations | 2 |
| Key findings | Psychedelic drugs are effective for treating depression, anxiety, obsessive-compulsive disorder, drug addiction, and mental problems associated with terminal disease, but mania and psychosis are linked to unfavorable outcomes. |
Abstract
In this review, studies focusing on the therapeutic use of psychedelics for treating mental health disorders published since 2010 have been examined. A systematic literature search was conducted using Medline and EBSCO. After extracting data from 19 papers, an analysis was performed. Critical evidence highlighting the effectiveness of psychedelic drugs in treating depression, anxiety, obsessive–compulsive disorder, drug addiction, and mental problems associated with terminal disease has been identified in the analyzed research. Guidelines for the safe administration of psychedelic therapy have been employed in all relevant primary studies. Nonetheless, mania and psychosis have been found to be linked to unfavorable outcomes. Although there has been a resurgence of research on the safety and effectiveness of psychedelics for a variety of mental health issues, the positive findings of this review reinforce the need for more comprehensive studies to better understand how psychedelics affect clients with mental illnesses. More studies are also required to examine the effectiveness of psychedelics in treating some mental illnesses, such as eating disorders, posttraumatic stress disorder, and personality disorders.
Citations in the library
Cites 43
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Psychopharmacology July 7, 2006
- Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder JAMA Psychiatry November 4, 2020
- Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. Psychopharmacology November 8, 2017
- Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial Psychological Medicine June 15, 2018
and 38 more in the library